Defectos de nacimiento (prevención)

Activated charcoal is a highly porous carbon material used in emergency medicine to adsorb ingested poisons and environmental toxins in the gastrointestinal tract. Its large surface area and negative electrical charge attract and bind positively charged toxins, preventing their absorption. It has established use in acute poisoning and is studied for binding certain heavy metals, chlorine, and industrial chemicals in the gut.

Alpha-lipoic acid (ALA) is a dithiol antioxidant studied for its potential to chelate heavy metals including mercury, lead, and cadmium. Its two sulfur atoms can bind metal ions, and it also upregulates glutathione synthesis and activates Nrf2-mediated phase II detoxification enzymes. Animal and small human studies support its adjunctive role alongside conventional chelators.

A large randomized clinical trial in Qidong, China, found that participants consuming a broccoli sprout beverage excreted significantly more benzene and acrolein metabolites in urine, indicating enhanced detoxification of airborne pollutants. This effect is driven by sulforaphane's induction of phase II detoxification enzymes via Nrf2.

Catalase activity is an established biomarker of oxidative stress caused by environmental toxin exposure. Studies document that heavy metal exposure (particularly lead) suppresses catalase activity and is associated with elevated blood pressure and organ damage. Catalase gene polymorphisms modulate susceptibility to lead-induced oxidative injury.

Chlorella is a freshwater microalga studied for its ability to bind heavy metals (mercury, lead, cadmium, arsenic) through biosorption and chelation mechanisms. Human studies include a PMC 2019 clinical trial showing 90-day supplementation reduced mercury and tin levels in patients with dental amalgam fillings. In vitro data demonstrate 90–95% cadmium binding in simulated gut fluid.

Chlorophyllin is the best-studied dietary chemoprotective agent against aflatoxin B1, a potent environmental mycotoxin and hepatocarcinogen. A landmark randomized, double-blind, placebo-controlled trial in 180 adults in Qidong, China—a region with very high dietary aflatoxin exposure—found that 100 mg chlorophyllin three times daily for 4 months produced a 55% reduction in urinary aflatoxin-DNA adduct biomarkers versus placebo. A subsequent Phase 0 human pharmacokinetic study confirmed chlorophyll and chlorophyllin reduce aflatoxin bioavailability in volunteers.

Chlorophyllin is the most robustly evidenced human intervention for dietary carcinogen interception. A landmark double-blind RCT (Kensler et al., PNAS 2001, n=180) in Qidong, China showed that 100 mg three times daily for 4 months reduced aflatoxin-DNA adducts in urine by 55% compared to placebo. Chlorophyllin acts as an 'interceptor molecule,' forming tight complexes with aflatoxin-B1 and other polycyclic aromatic hydrocarbons in the GI tract, blocking absorption.

Citrus pectin, particularly in modified form (MCP), can bind environmental toxins including heavy metals in the gastrointestinal tract and bloodstream, facilitating their excretion. Native pectin binds metals in the gut lumen before absorption; MCP reaches systemic circulation and chelates metals already absorbed.

Clinoptilolite is a naturally occurring zeolite mineral whose cage-like aluminosilicate lattice binds and traps heavy metals (mercury, cadmium, lead, arsenic, thallium) and mycotoxins via ion exchange in the GI tract. Clinical studies document reduced blood mercury and cadmium after 28-day supplementation, and improved blood arsenic after 12 weeks.

D-glucarate enhances Phase II liver detoxification (glucuronidation), facilitating excretion of lipid-soluble environmental carcinogens and xenobiotics by inhibiting the gut enzyme beta-glucuronidase. Urinary D-glucaric acid excretion is a recognized biomarker for xenobiotic exposure. Preclinical evidence is robust; preliminary human data support biochemical efficacy but large clinical trials are lacking.

Dimercaptosuccinic acid (DMSA) is a water-soluble dithiol compound and established pharmaceutical chelating agent for heavy metal poisoning. It is recommended by poison control centers worldwide for lead poisoning in children and is used for mercury, arsenic, and cadmium toxicity. Its dithiol groups form stable, water-soluble complexes with toxic metals, facilitating urinary excretion.

Fulvic acid is a low-molecular-weight humic substance formed from organic matter decomposition in soil. It contains multiple binding sites that interact with heavy metals (lead, mercury, cadmium), pesticides, and pollutants, potentially reducing their bioavailability in the gut. Laboratory and animal studies show reduced metal accumulation; human data are limited but preliminary.

Garlic contains organosulfur compounds, principally allicin, which exhibit chelating properties for heavy metals including lead, mercury, and cadmium. A human clinical study found garlic extract as effective as D-penicillamine in reducing lead levels in industrial workers, with fewer side effects. Animal studies confirm reduction of mercury, cadmium, and lead accumulation in liver tissue.

Humic acid is a large-molecular-weight fraction of humic substances that binds environmental toxins including heavy metals and mycotoxins in the gastrointestinal tract, primarily preventing their absorption and facilitating fecal excretion. Laboratory and animal studies document this binding capacity; human clinical data remain limited.

Indole-3-carbinol (I3C), derived from glucobrassicin in cruciferous vegetables, is among the most potent natural inducers of phase II detoxification enzymes. These enzymes (glutathione S-transferases, quinone reductase, NQO1) are critical for metabolizing and eliminating environmental carcinogens, xenobiotics, and chemical pollutants from the body.

L-cysteine is the rate-limiting substrate for glutathione biosynthesis, and glutathione is the body's primary conjugating agent for Phase II liver detoxification of environmental toxins. Increasing L-cysteine supply directly upregulates the capacity to neutralize and eliminate xenobiotics, aromatic amines, and other environmental pollutants via glutathione-S-transferase reactions.

Glutathione is the body's primary phase-II conjugating agent for xenobiotics, heavy metals, and environmental pollutants, facilitating their elimination via the liver and kidneys. GSH conjugates toxins via glutathione-S-transferase (GST) enzymes, making them water-soluble for biliary or renal excretion. This is a well-established biochemical mechanism with clinical relevance (e.g., N-acetylcysteine as GSH precursor in acetaminophen overdose).

L-methionine supports hepatic phase II detoxification of xenobiotics by providing the cysteine needed for glutathione synthesis, and is clinically used in acetaminophen overdose to replenish GSH and prevent hepatotoxicity. It also aids excretion of heavy metals such as lead and mercury through sulfur chelation and supports selenium and zinc absorption. Animal data show L-methionine counteracts methotrexate-induced nephrotoxicity.

Milk thistle (Silybum marianum) contains silymarin, a flavonoid complex that protects hepatocytes from damage caused by environmental toxins (heavy metals, alcohol, acetaminophen, carbon tetrachloride, pesticides) by scavenging free radicals, enhancing glutathione levels, inhibiting lipid peroxidation, and modulating cytochrome P450 and phase II detoxification enzymes.

Molybdenum is a required cofactor for aldehyde oxidase and mARC, enzymes that perform phase I detoxification of environmental aldehydes, N-hydroxylated compounds, and various xenobiotics in the liver. Xanthine oxidase also contributes to metabolism of heterocyclic environmental compounds. These roles are mechanistically established in human biochemistry and reviewed in peer-reviewed literature.

N-acetyl cysteine (NAC) is a cysteine precursor that replenishes glutathione, the master antioxidant and primary hepatic chelator for heavy metals and environmental toxins. It has demonstrated chelating activity for mercury, lead, arsenic, and cadmium in both animal and human studies, and is used clinically as an adjunctive agent in heavy metal toxicity management.

Silymarin, specifically its purified component silibinin (silybin), has documented clinical use as an antidote to Amanita phalloides (death cap mushroom) poisoning. It blocks hepatocellular uptake of amatoxins via competitive inhibition. Intravenous silibinin (Legalon-SIL) has been used in European emergency settings with high survival rates. It also shows hepatoprotection against drug-induced and chemotherapy-related liver toxicity in clinical trials.

Spirulina (Arthrospira platensis) is a blue-green algae with chelating activity and antioxidant compounds (phycocyanin, beta-carotene) that protect against heavy metal-induced oxidative damage. A clinical study found spirulina plus zinc reduced urinary arsenic levels and improved skin manifestations in arsenic-contaminated children. 58 preclinical studies and 5 clinical studies support its use against arsenic, cadmium, lead, and mercury toxicity.

Sulforaphane is an isothiocyanate derived from glucoraphanin in broccoli sprouts and a potent inducer of phase II detoxification enzymes (NQO1, glutathione S-transferases) via Nrf2 activation. Clinical studies in Qidong, China (n=200) demonstrated that daily broccoli sprout infusion significantly enhanced urinary excretion of the carcinogen aflatoxin and the pollutant phenanthrene, representing direct human evidence for environmental toxin detoxification.

Zeolite (particularly clinoptilolite type) is a volcanic aluminosilicate mineral whose cage-like pore structure traps heavy metal cations (mercury, cadmium, lead, arsenic) and mycotoxins via ion exchange in the GI tract. Clinical studies document reduced blood mercury and cadmium after 28 days, and improved blood arsenic after 12 weeks of supplementation.